Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH3RESA: Trastuzumab Emtansine vs Physician's Choice in Advanced HER2+ Breast Cancer
NCT01419197Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of trastuzumab emtansine in breast cancer, sponsored by Roche. Started Sep 2011; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01419197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419197.